Sharon Rosenzweig-Lipson, AgeneBio VP of R&D. presents at Clinical Trials in Alzheimer’s Disease conference (CTAD)

Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.

« back to Press Releases

December 7, 2019

Sharon Rosenzweig-Lipson, AgeneBio VP of R&D. presents at Clinical Trials in Alzheimer’s Disease conference (CTAD)

Read More